Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma

Cancer Genetics and Cytogenetics

Volumn 199, Issue 2, 2010, Pages 128-133

  Antonelli, Alessandro ^a   Tardanico, Regina ^a   Balzarini, Piera ^a   Arrighi, Nicola ^a   Perucchini, Laura ^a   Zanotelli, Tiziano ^a   Cozzoli, Alberto ^a   Zani, Danilo ^a   Cunico, Sergio Cosciani ^a   Simeone, Claudio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SURVIVAL; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 12; CHROMOSOME 15; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 18; CHROMOSOME 20; CHROMOSOME 22; CHROMOSOME 5; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME 8; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; GENETIC ANALYSIS; HUMAN; KARYOTYPE; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME; TYPE 1 PAPILLARY RENAL CELL CARCINOMA; TYPE 2 PAPILLARY RENAL CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CHROMOSOME ABERRATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KARYOTYPING; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 77952753366     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.02.013     Document Type: Article

References (30)

1. Eble J.N. World Health Organization. Pathology and Genetics of tumours of the urinary system and male genital organs 2004, IARC Press & Oxford University Press, Lyon.
2. Delahunt B., Eble J.N. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol 1997, 10:537-544.
3. Limon J., Dal Cin P., Sandberg A.A. Application of long-term collagenase disaggregation for cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 1986, 23:305.
4. Mancilla-Jimenez R., Stanley R.J., Blath R.A. Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer 1976, 38:2469-2480.
5. Amin M.B., Corless C.L., Renshaw A.A., Tickoo K., Kubus J., Schultz D.S. Papillary (chromophil) renal cell carcinoma: histomorphologic charateristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 1997, 21:621-635.
6. Moch H., Gasser T., Amin M.B., Torhost J., Sauter G., Mihatsch M.J. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma. A Swiss experience with 588 tumors. Cancer 2000, 89:604-614.
7. Margulis V., Tamboli P., Matin S.F., Swanson D.A., Wood C.G. Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma. Cancer 2008, 112:1480-1488.
8. Cheville J.C., Lohse C.M., Zincke H., Weaver A.L., Blute M.L. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003, 27:612-624.
9. Patard J.J., Leray E., Rioux-Leclercq N., Cindolo L., Ficarra V., Zisman A., et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol 2005, 23:2763-2771.
10. Ficarra V., Martignoni G., Galfano A., Novara G., Gobbo S., Brunelli M., et al. Prognostic role of the histologic subtypes of renal cell carcinoma after slide revision. Eur Urol 2006, 50:786-793.
11. Leroy X., Zini L., Leteurtre E., Zerimech F., Porchet N., Aubert J.P., et al. Morphological subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypes. Mod Pathol 2002, 15:1126-1130.
12. Pignot G., Elie C., Conquy S., Viellefond A., Flam T., Zerbib M., Debrè M., Amsellem-Ouazana A. Survival analysis of 130 patients with papillary renal cell carcinoma. Prognostic utility of type 1 and type 2 subclassification. Urology 2007, 69:230-235.
13. Mèjan A., Hopirtean V., Bazin J.P., Larousserie F., Benoit H., Chretien Y., et al. Prognostic factors for the survival of patients with papillary renal cell carcinoma: meaning of histological typing and multifocality. J Urol 2003, 170:764-767.
14. Gontero P., Ceratti G., Guglielmetti S., Andorno A., Terrone C., Bonvini D., et al. Prognostic factors in a prospective series of papillary renal cell carcinoma. BJU Int 2008, 102:697-702.
15. Waldert M., Haitel A., Marberger M., Katzenbeisser D., Ozsoy M., Stadler E., et al. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC. BJU Int 2008, 102:1381-1384.
16. Kovacs G. Molecular differential pathology of renal cell tumours. Histopathology 1993, 22:1-8.
17. Bugert P., Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol 1996, 149:2081-2088.
18. Corless C.L., Aburatani H., Fletcher J.A., Housman D.E., Amin M.B., Weinberg D.S. Papillary renal cell carcinoma: quantitation of chromosomes 7 and 17 by FISH, analysis of chromosome 3p for LOH, and DNA ploidy. Diagn Mol Pathol 1996, 5:53-64.
19. Schmidt L., Junker K., Nakaigawa N., Kinjerski T., Wirich G., Miller M., et al. Novel mutations of the MET proto-oncogene in papillary renal cell carcinomas. Oncogene 1999, 18:2343-2350.
20. Bentz M., Bergerheim U.S.R., Li C., Joos S., Werner C.A., Baudis M., et al. Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analysed by comparative genomic hybridization. Cytogenet Cell Genet 1996, 75:17-21.
21. Palmeto G., Fischer J., Kovacs G. Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.2 and between loci D20S902 and D20S480 at 20q13.2 mark new tumor genes in papillary renal cell carcinoma. Lab Invest 1999, 79:311-326.
22. Jiang F., Richter J., Schraml P., Bubendorf L., Gasser T., Sauter G., Mihatsch M.J., Moch H. Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histologic subtypes. Am J Pathol 1998, 153:1467-1473.
23. Sanders M.E., Mick R., Tomaszewski J.E., Barr F.G. Unique patterns of allelic imbalance distinguish type 1 from type 2 sporadic papillary renal cell carcinoma. Am J Pathol 2002, 161:997-1005.
24. Gunawan B., von Heydebreck A., Fritsch T., Huber W., Ringert R.H., Jackse G., et al. Cytogenetic and morphologic typing of 58 papillary renal cell carcinomas: evidence for a cytogenetic evolution of type 2 from type 1 tumors. Cancer Res 2003, 63:6200-6205.
25. Yang X.J., Tan M.H., Kim H.L., Ditlev J.A., Betten M.W., Png C.E., et al. A molecular classification of papillary renal cell carcinoma. Cancer Res 2005, 65:5628-5637.
26. Klatte T., Pantuck A.J., Said J.W., Seligson D.B., Rao N.P., LaRochelle L.C., et al. Cytogenetic and molecular tumor profiling for type 1 and type 2 apillary renal cell carcinoma. Clin Cancer Res 2009, 15:1162-1169.
27. Delahunt B., Eble N., McCredie M.R.E., Bethwaite P.B., Stewart J.H., Bilous A.M. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient urvival in 66 cases. Hum Pathol 2001, 32:590-595.
28. Furge K.A., Chen J., Koeman J., Swiatek P., Dykema K., Lucin K., et al. Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res 2007, 67:3171-3176.
29. Davis I.J., Hsi B.L., Arroyo J.D., Vargas S.O., Yeh Y.A., Motyckova G., Valencia P., et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA 2003, 100:6051-6056.
30. Meloni A.M., Dobbs R.M., Pontes J.E., Sandberg A.A. Translocation (X;1) in papillary renal cell carcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet 1993, 65:1-6.